Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review. [PDF]
, 2014 D'Amato G +8 more
core +1 more source
Response to comments on "Effectiveness of transitioning from omalizumab to dupilumab in chronic spontaneous urticaria patients with inadequate response to omalizumab". [PDF]
World Allergy Organ JHayama K, Ito-Watanabe M, Fujita H.
europepmc +1 more source
Twelve-year follow-up of omalizumab therapy for anaphylaxis in 2 patients with systemic mastocytosis
, 2018 Gregory Constantine +4 more
openalex +2 more sources
Efficacy of omalizumab in the treatment of STAT3 loss-of-function mutations associated with autosomal dominant hyperimmunoglobulin E syndrome-a case report. [PDF]
Transl PediatrLi H +8 more
europepmc +1 more source
Omalizumab to dupilumab switch in chronic spontaneous urticaria. [PDF]
World Allergy Organ JÖzdemir Ö.
europepmc +1 more source
Omalizumab in the Treatment of Chronic Urticaria during Pregnancy [PDF]
Siyuan Geng, Tao Cai
openalex +1 more source
Novel Treatment of Allergic Fungal Sinusitis Using Omalizumab [PDF]
, 2014 Martin Oman Evans, Christopher A. Coop
openalex +1 more source
A Prospective Observational Study Evaluating the Efficacy of Omalizumab and Mepolizumab in Patients With Severe Asthma. [PDF]
CureusMakhlooq M +6 more
europepmc +1 more source